AML (Acute Myeloid Leukemia),Leukemia Venetoclax and Hypomethylating Agents vs HAG in AML May 20, 2024
AML (Acute Myeloid Leukemia),Leukemia Efficacy of GO-Based AML Treatment: Low vs. Intermediate Risk May 15, 2024
ALL (Acute Lymphoblastic Leukemia),Leukemia Enhancing CAR T-Cell Therapy in Leukemia: Beyond CD22 May 14, 2024
ALL (Acute Lymphoblastic Leukemia),Leukemia Optimal PEGasparaginase Dosing for Infants With ALL May 14, 2024
ALL (Acute Lymphoblastic Leukemia),Leukemia Impact of CLO in Adult ALL: Survival Insights May 10, 2024
AML (Acute Myeloid Leukemia),Leukemia Enhanced AML Treatment: VEN+AZA vs. AZA Monotherapy May 09, 2024
AML (Acute Myeloid Leukemia),Leukemia miR-133a & miR-135a Shows Promise in Pediatric AML Therapy May 09, 2024
